Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
Join a leading global firm as an Equity Research Analyst or Associate within the Pharma & Biotech team. This role focuses on providing detailed analyses and insights on market trends and equity performance. You'll work collaboratively with experienced analysts and engage directly with clients, enhancing your professional development within a supportive environment.
Equity Research is part of J.P. Morgan’s number 1 ranked Global Research franchise. Each team is grouped by sector expertise and aims to provide actionable ideas and thematic insights that empower our institutional clients to make well-informed and strategic investment decisions. We bring clarity to complex situations through extensive sector knowledge and a deep understanding of global markets.
As an Equity Research Analyst or Associate within the Pharma & Biotech Equity Research Team, you will be tasked with cultivating a deep understanding of equities, markets, and companies, with a special emphasis on the Pharma & Biotech sector.Your role will involve collaborating closely with our top-tier team under the mentorship of senior analysts to create insightful reports on companies, sectors, and thematic trends. You will also be responsible for conveying our team's insights on stocks and sectors to our institutional clients. Beyond your immediate team duties, you will be a part of a community of intelligent, inquisitive, and collaborative team members who are given substantial responsibility and exposure early in their careers. We provide extensive training and professional development across the department to support career progression.
Job Responsibilities
Required Qualifications, Capabilities, and Skills
Preferred qualifications, capabilities, and skills
This role encompasses the performance of UK regulated activity. The successful candidate will therefore be subject to meeting UK regulatory requirements in the assessment of fitness, propriety, knowledge and competence (as assessed by the Firm) and (where appropriate) approval by the UK Financial Conduct Authority and/or the Prudential Regulation Authority to carry out such activities.